Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Genetic and Dietary Predictors of Aspirin Response in AI/AN Populations
NCT04456608Phase 4Terminated
- Sponsor
- University of Washington
- Start
- Aug 2016
- Primary completion
- Jul 2023
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of aspirin in cardiovascular diseases (CVD), sponsored by University of Washington. Started Aug 2016; status: terminated.
02
Drugs
aspirin
03
Conditions
cardiovascular diseases (CVD)
Beyond the preview
Go deeper on NCT04456608.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04456608.